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ABSTRACT
Non-exudative age-related macular degeneration, a prevalent cause
of blindness, is a progressive and degenerative disease characterized
by alterations in Bruch’s membrane, retinal pigment epithelium,
and photoreceptors exclusively localized in the macula. Although
experimental murine models exist, the vast majority take a long time to
develop retinal alterations and, in general, these alterations are
ubiquitous, with many resulting from non-eye-specific genetic
manipulations; additionally, most do not always reproduce the
hallmarks of human age-related macular degeneration. Choroid
vessels receive sympathetic innervation from the superior cervical
ganglion, which, together with the parasympathetic system, regulates
blood flow into the choroid. Choroid blood flow changes have been
involved in age-related macular degeneration development and
progression. At present, no experimental models take this factor
into account. The aim of this work was to analyze the effect of superior
cervical gangliectomy (also known as ganglionectomy) on the choroid,
Bruch’s membrane, retinal pigment epithelium and retina. Adult
male C57BL/6J mice underwent unilateral superior cervical
gangliectomy and a contralateral sham procedure. Although superior
cervical gangliectomy induced ubiquitous choroid and choriocapillaris
changes, it induced Bruch’s membrane thickening, loss of retinal
pigment epithelium melanin content and retinoid isomerohydrolase,
the appearance of drusen-like deposits, and retinal pigment epithelium
and photoreceptor atrophy, exclusively localized in the temporal
side. Moreover, superior cervical gangliectomy provoked a localized
increase in retinal pigment epithelium and photoreceptor apoptosis,
and a decline in photoreceptor electroretinographic function.
Therefore, superior cervical gangliectomy recapitulated the main
features of human non-exudative age-related macular degeneration,
and could become a new experimental model of dry age-related
macular degeneration, and a useful platform for developing new
therapies.
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INTRODUCTION
Age-related macular degeneration (AMD) is a leading cause of
irreversible blindness among people above 60 years old in
industrialized countries (Jager et al., 2008; Wong et al., 2014). It
is estimated to have a prevalence of ∼18% in the population aged
65-74 years (Klein et al., 1992), and the general consensus states
that, as the population grows and ages, the incidence of the disease
will increase (Buschini et al., 2015). AMD is a heterogeneous
disease, presenting several signs such as accumulation of debris and
deposits both below (drusen) and above (pseudodrusen) the retinal
pigment epithelium (RPE), thickening of Bruch’s membrane
(BrM), hyper or hypopigmentation of the RPE, choroidal
neovascularisation (CNV) and loss of photoreceptors (PRs)
(Bhutto and Lutty, 2012; Jager et al., 2008). Clinically, AMD has
been classified in two forms: non-exudative AMD (the more
prevalent form of the disease) and exudative or neovascular AMD
(NVAMD). Although the two forms might not necessarily be
mutually exclusive, the hallmark of NVAMD is CNV, whereas non-
exudative AMD is characterized by a delimited central area of RPE
atrophy and PR loss, which in advanced stages is called geographic
atrophy (GA) (Bhutto and Lutty, 2012; Jager et al., 2008; van
Lookeren Campagne et al., 2014). Currently, there is no approved or
effective treatment to prevent the onset and progression of GA.
Several environmental aspects, such as old age, female sex, cigarette
smoking, diet and Caucasian race, have been identified as risk
factors for AMD (Buschini et al., 2015; Danis et al., 2015; van
Lookeren Campagne et al., 2014; Zarbin, 2004). In addition,
oxidative stress, inflammation, RPE senescence and choroid blood
flow changes are involved in AMD development and progression
(Buschini et al., 2015; Danis et al., 2015; van Lookeren Campagne
et al., 2014; Zarbin, 2004). However, the exact pathogenic
mechanisms and their temporal sequence are still elusive. AMD is
difficult to study because of its late onset, complex genetics and the
influence of environmental factors. Unravelling which are the most
critical mechanisms in AMD pathogenesis is unlikely to be
achieved in studies limited to the clinically observable changes in
human retinas. Far more detailed and invasive studies are needed,
preferably in a readily available animal model. Over the last decade,
there have been an increasing number of reports describing rodent
models (mostly mice), which show some characteristics compatible
with human AMD (Fletcher et al., 2014; Pennesi et al., 2012;
Ramkumar et al., 2010). The majority of these models result from
the manipulation of mouse genes involved in inflammation (CFH,
CCL2, CCR2, CX3CR1) and oxidative stress (SOD1 and SOD2), as
well as genes related to metabolic pathways (CTSD, CP and APOE),
among others (Fletcher et al., 2014; Pennesi et al., 2012; RamkumarReceived 4 August 2017; Accepted 28 November 2017
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et al., 2010). Other models include the use of a mouse strain of
accelerated senescence (Majji et al., 2000) and immunization with
carboxyethylpyrrole, an oxidative product of docosahexaenoic acid
(Hollyfield et al., 2010). However, most of these models show
AMD-like retinal changes only in old mice (12-24 months old),
incorporating an established risk factor (aging), but precluding a
rapid time course to allow more efficient studies, and adding
an experimental difficulty because increased animal age is
associated with high mortality. In addition, genetic manipulations
are frequently not specific for the ocular tissues, and the retinal
lesions provoked tend to be ubiquitous rather than geographic,
contrary to one of the most striking findings in human dry AMD,
which affects almost exclusively the macular area. Other non-
exudative AMD models are induced by the systemic injection of
sodium iodate, a relatively specific oxidant of the RPE (Carido et al.,
2014), and a long-term exposure to high intensity light (Bordone
et al., 2012). However, in these models, retinal damage occurs
acutely, which is far different from the chronic and progressive
changes found in human AMD. Although impairment of choroidal
blood flow is one of the supposed pathogenic mechanisms of AMD
(Ciulla et al., 1999; Friedman, 2008; Friedman et al., 1995), at
present, there are no experimental models of the disease that
specifically take into account this risk factor.
Oxygen and nutrients are supplied to the RPE and the outer retina
exclusively by choroid blood flow through the BrM. Choroid
blood flow is one of the highest (in volume per unit time) of the
entire vascular system, providing ∼80% of the retinal blood supply,
which ensures a source of oxygen and nutrients mainly to the PR
layer. Choroid vessels receive sympathetic innervation from the
superior cervical ganglion (SCG) (Bill, 1985; Koss, 1994; Triviño
et al., 2005), which triggers vasoconstriction and, altogether with
parasympathetic terminals inducing vasodilatation, regulates the
flow rate through the choroid (reviewed by Nickla and Wallman,
2010). It has been shown that superior cervical gangliectomy (SCGx)
induces choroid hemodynamic alterations (Steinle et al., 2002), and
that a decrease in choroid blood flow correlates with BrM
thickening (Pauleikhoff et al., 1990) and drusen extension
(Berenberg et al., 2012). Since maintenance of an adequate
choroid blood flow is essential for the proper functioning of the
RPE and PRs, and that a decrease in choroid blood flow could play
an important role in AMD pathogenesis, the aim of this work was to
analyze the effect of SCGx on C57BL/6J mouse choroid,
choriocapillaris, BrM and retina.
RESULTS
Representative photomicrographs of the choroid from sham-treated
eyes, and eyes submitted to SCGx at 4, 6 and 10 weeks post-surgery,
are shown in Fig. 1. SCGx induced an increase in choroidal thickness
at 4 weeks, and this was more evident at 6 and 10 weeks post-SCGx.
No differences in choroid melanin content were observed between
control and SCGx eyes 10 weeks post-surgery (data not shown). A
detailed analysis of the choriocapillaris showed a significant increase
in its thickness both at the nasal and temporal side of the optic nerve
head (ONH) at all time points studied. The sham procedure did not
affect the choroid or choriocapillaris thickness (Fig. 1). No major
alterations were observed among the fundus pictures of naïve,
controls and eyes at 10 weeks post-SCGx (Fig. S1). SCGx induced a
ubiquitous decrease in tyrosine hydroxylase (TH) immunoreactivity
in the choroid, but not in the retina, at 4 and 10 weeks post-surgery.
Choroid TH -immunoreactivity was similar in naïve and sham-treated
eyes (Fig. S2). BrM ultrastructure was evaluated at the nasal and
temporal side of the ONH at different intervals post-surgery.
Alterations in BrM ultrastructure, the presence of mid electron
density deposits below the RPE basal membrane and a significant
increase in its thickness were observed in the temporal (but not nasal)
side at 6 weeks post-SCGx, followed by an increase in fibrillar
collagen content and areas with endothelial cell loss at 10 weeks post-
SCGx (Fig. 2). Representative photomicrographs of the nasal and
temporal RPE at 800 µm from the ONH are shown in Fig. 3. SCGx
induced a significant decrease in melanin content in the temporal
RPE, which, at 4 weeks after SCGx, was evident at 800 µm
temporally from the ONH, and afterwards spread in a time-
dependent fashion to almost all the temporal side, except for the
periphery (1600-2000 µm from the ONH), at 6 and 10 weeks post-
SCGx (Fig. 3A). Representative photomicrographs of RPE65
immunostaining at 800 µm from the ONH are also shown
(Fig. 3C). A clear decrease in RPE65 immunoreactivity in the
temporal RPE was observed at 4, 6 and 10 weeks post-SCGx
(Fig. 3C). Nasal RPE melanin content and RPE65 immunoreactivity
did not differ among groups at all time points studied. The effect of
SCGx on the nasal and temporal retinal structure is shown in Fig. 4.
Besides melanin loss, no major morphological changes in the nasal
and temporal retinal structure were observed at 4 weeks post-surgery,
whereas, at 6 and 10 weeks post-SCGx, drusenoid deposits were
detected between RPE and PRs at 800 µm temporally from the ONH,
without any obvious morphological alterations in PRs (Fig. 4).
Moreover, RPE vacuolization in the temporal area was observed at
10 weeks post-SCGx. C3 immunostaining is also shown in Fig. 4. No
C3 immunoreactivity was detected in sham-treated eyes or at 4 weeks
after SCGx, whereas, at 6 and 10 weeks post-SCGx, the presence of
C3(+) linear deposits below the temporal RPE was observed (Fig. 4).
No structural alterations or C3 immunoreactivity were found in the
nasal retina from all experimental groups. Fig. 4 also shows a
significant increase in apoptotic cell number in the temporal outer
nuclear layer (ONL) and RPE at 10 weeks post-SCGx, whereas no
apoptotic cells were found in the nasal ONL and RPE, or in other
retinal layers, at all time points in control retinas. There was no
histological evidence of CNV, hemorrhages, serous exudates or
edema in the neuroretina at any time point in any experimental group.
In order to further analyze the effect of SCGx on the retina, retinal
morphometry (Fig. S3), GFAP immunoreactivity and Brn3a(+)
retinal ganglion cell (RGC) number (Fig. S4) were analyzed. No
differences in any of these parameters were observed in the nasal and
temporal retina in all experimental groups at all time points. The
average amplitudes of scotopic electroretinogram (ERG) a- and b-
wave and oscillatory potentials (OPs), as well as representative
scotopic ERG traces, are shown in Fig. 5. In the ipsilateral retina,
SCGx induced a significant decrease in ERG a-wave amplitude,
which was greater at 6 and 10 weeks post-surgery (Fig. 5), whereas
ERG b-wave and OP amplitudes did not change at all time points
studied. In addition, no differences were observed between naïve eyes
and control eyes in any of these parameters. The ERG a- and b-wave
and OP latencies remained unchanged among groups (data not
shown). The ultrastructural analysis showed the presence of vacuoles
adjacent to RPE basal infoldings at 6 weeks post-SCGx. These
changes were greater, and vacuoles appeared more apical and often
filled with membranous content, at 10 weeks post-SCGx (Fig. 6). An
increase in the number of granules likely containing lipofuscin and
melanolipofuscin was also evident in the temporal RPE at 10 weeks
post-SCGx. In the temporal retina, a clear disorganization of the
membranous discs, focal loss of outer segment plasmatic membrane,
and open discs were observed at 6 weeks post-SCGx (Fig. 6). At
10 weeks post-SCGx, PR blebs with complete disc loss, more evident
outer segment membrane losses, and amorphous electron-dense
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material replacing outer segments were observed exclusively in the
temporal retina. No alterations were found in control retinas along the
study.
DISCUSSION
For the first time, the foregoing results demonstrate that SCGx
induces ubiquitous choroid and choriocapillaris morphological
changes, as well as BrM thickening, melanin and RPE65 loss, the
occurrence of drusenoid deposits, RPE atrophy, and structural
alterations in PRs exclusively localized in the temporal (but not
nasal) region, mimicking central features of human GA.
As expected, the sympathetic denervation induced TH
immunoreactivity loss in the ipsilateral choroid, but not in the
retina, from C57BL/6J mice. In addition, SCGx provoked
ubiquitous distension of the choroid at 4 weeks, which persisted
at 6 and 10 weeks post-surgery. An increase in choroid thickness
was previously described by Steinle et al. (2002) in female Sprague-
Dawley rats at 6 weeks post-SCGx that was attributed to an increase
in choroidal venule number and larger choroidal arterioles.
Although we did not assess these parameters in our experimental
setting, the present results further support choroid thickness
regulation by the SCG. Moreover, Steinle and co-workers (Steinle
Fig. 1. Effect of SCGx on the choroid. (A) Transverse ultrathin sections of the choroid from control and SCGx eyes at 4, 6 and 10 weeks post-surgery. SCGx
induced an increase in choroidal thickness (black bars), tissue spreading, and vessels enlargement. (B) Choriocapillaris details from control and SCGx eyes at 4,
6 and 10 weeks post-surgery. A significant increase in nasal and temporal choriocapillaris thickness (black bars) was found in eyes submitted to SCGx at all time
points. (C) Quantification of choriocapillaris thickness from control and SCGx eyes at 4, 6 and 10 weeks post-surgery. SCGx induced a significant increase in the
nasal and temporal choriocapillaris thickness at 4 and 10 weeks post-surgery. Shown are representative photomicrographs from five animals/group. BrM, Bruch’s
membrane; ChC, choriocapillaris; Ch, choroid; Sc, sclera; C, control; SCGx, superior cervical gangliectomy. Scale bars: 5 µm. Data are means±s.e.m. (n=5
animals per group), **P<0.01 vs control eyes at 10 weeks post-SCGx, by Student’s t-test.
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et al., 2002) reported that SCGx induces abnormal vascular
proliferation, whereas new blood vessel formation from the
choroid (CNV) that is characteristic of exudative AMD was not
observed in C57BL/6J mice at least at 10 weeks post-SCGx. This
inconsistency may be due to age-, gender- and species-specific
differences.
A role for choriocapillaris dysfunction in AMD onset and
progression has been suggested (Biesemeier et al., 2014; Nesper
et al., 2017); however, to our knowledge, the choriocapillaris
thickness has not been previously assessed in any other
experimental model of AMD. Notably, a similar appearance of
the choroid and choriocapillaris was shown in an experimental
model of AMD induced by the deletion of SOD2 in the mouse RPE
(Mao et al., 2014), although, in this case, the choriocapillaris
thickness was not specifically measured.
BrM lies between the choriocapillaris and the RPE, and it is a well-
established ‘player’ in AMD pathogenesis (Bhutto and Lutty, 2012;
Zarbin, 2004). Given its acellularity, transport across BrM primarily
occurs through passive diffusion. Therefore, BrM thickening could
alter its diffusion properties and, consequently, RPE and outer-retina
nutrition and functioning (Bhutto and Lutty, 2012; Grindle and
Marshall, 1978). The thickening of BrM has been observed in early
and late stages of human AMD (Karampelas et al., 2013); however,
the occurrence of BrM changes is less common in animal models of
AMD (Ramkumar et al., 2010). Despite the widespread alteration in
the choroid and choriocapillaris, SCGx induced BrM thickening only
in the temporal (but not nasal) side at 6 and 10 weeks post-surgery.
Moreover, areas with no endothelial cells adjacent to the temporal
BrM were identified at 10 weeks after SCGx. In agreement, the loss
of choriocapillaris endothelial cells has been proposed as a key
contributor in human AMD (Chirco et al., 2017).
Eyes with non-exudative AMD are characterized by
accumulation of focal extracellular-lipid- and protein-rich deposits
below the RPE cells and/or within BrM, including drusen, basal
laminar and basal linear deposits, which are associated with RPE
dysfunction and apoptosis (Curcio et al., 2005; Hu et al., 2013;
Sarks et al., 1999). Another form of retinal deposits, called reticular
pseudodrusen, which, unlike conventional drusen, is located at a
Fig. 2. Ultrastructural analysis of Bruch’smembrane (BrM). (A) Transverse ultrathin sections from control and SCGx eyes at 4, 6 and 10 weeks post-surgery.
At 4 weeks post-SCGx, BrM thickness and structurewere preserved, whereas, at 6 weeks post-surgery, SCGx induced a significant thickening and a clear loss of
its pentalaminar structure, followed by fibrillar collagen accumulation (white arrow), reticular middle electron-dense deposits under the RPE basal membrane
(asterisk) and absence of endothelial cells (black arrow) at 10 weeks post-SCGx. Shown are representative photomicrographs at 800 µm, nasally and temporally,
from the ONH, from five animals/group. (B) Quantification of nasal and temporal BrM thickness in control eyes and eyes submitted to SCGx at 4, 6 and 10 weeks
post-surgery. SCGx induced a significant increase in the thickness of the temporal (but not nasal) BrM after 6 and 10 weeks post-surgery. BI, RPE basal
infoldings; BM, basal membrane; IC, internal collagenous layer; EL, elastic layer; OC, outer collagenous layer; EC, endothelial cell; Ch, choroid. Scale bar:
500 nm. Data are means±s.e.m. (n=5 animals per group), **P<0.01 vs control eyes, by Tukey’s test.
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subretinal level, was associated with an increased risk for GA
development (Fletcher et al., 2014). Small drusenoid deposits in
some experimental models of AMD (Ramkumar et al., 2010; Seo
et al., 2012) were mainly observed between the apical pole of the
RPE and the PR outer segments (i.e. pseudodrusen), a difference
that has been attributed to a simpler BrM, a different process of
lipofuscin extrusion compared with humans and to the manner in
which lipids are transported across the RPE in rodents (Fletcher
et al., 2014;Mishima and Kondo, 1981; Ramkumar et al., 2010). An
inverse correlation between choroidal blood flow and pseudodrusen
area has been reported (Berenberg et al., 2012). Notably, the choroid
sympathetic denervation provoked the presence of pseudodrusen
deposits in the temporal (but not nasal) side. Several complement
cascade components such as complement factors C3, C3b and
C5 are known constituents of drusenoid deposits (Johnson et al.,
2001; Mullins et al., 2000; Yao et al., 2015). In this line, sub-RPE
basal laminar-like deposits containing C3 were observed at 6 and
10 weeks post-SCGx, whereas no C3 immunoreactivity was
detectable in the contralateral side submitted to a sham procedure.
RPE cell dysfunction plays a central role in the subsequent PR
alterations and is an important feature of AMD (Bhutto and Lutty,
2012; Jager et al., 2008; Zarbin, 2004). Melanin in the RPE absorbs
light and serves as a first-line defense against PR photo-oxidation.
Hyper or hypopigmentation of the macular RPE are classic findings
in human (Bhutto and Lutty, 2012; Bird et al., 1995) and
experimental (Rakoczy et al., 2006; Ramkumar et al., 2010)
AMD. At 4 weeks post-SCGx, a loss of melanin content limited to a
small area of the temporal side, which progressed to almost all (with
the exception of the periphery) temporal RPE at 10 weeks post-
SCGx, was observed. Damage to the RPE induced by SCGx was
further supported by the loss of RPE65, an isomerohydrolase that
produces 11-cis-retinol from all-trans-retinyl esters, which is
specifically localized in the RPE and plays a key role in the visual
cycle. Also, in this case, the decrease in RPE65 levels was observed
only in the temporal RPE and already at 4 weeks after SCGx. The
retinal structural damage induced by SCGx seemed to be
exclusively localized in RPE and PR layer, as shown by the fact
that retinal layer thickness, and GFAP (a marker for damaged
Müller cells) and Brn3a (a specific marker for RGCs)
immunoreactivity did not change after surgery at least at 10 weeks
post-SCGx. It is well established that, in GA, RPE cells and PRs
degenerate and die (Bhutto and Lutty, 2012; van Lookeren
Campagne et al., 2014; Zarbin, 2004), and apoptotic PRs and
RPE cells were observed in human AMD (Dunaief et al., 2002). In
agreement, RPE and PR apoptotic cells were found in the temporal
(but not nasal) retina from eyes submitted to SCGx.
Although not routinely used as a tool for AMD diagnosis,
electroretinography can be useful to detect retinal dysfunctions
arising from retinal diseases, including AMD (Justilien et al., 2007).
In fact, some reports show a decreased ERG response in patients with
AMD (González-García et al., 2016; Yang et al., 2016). The ERG a-
wave is classically considered an index of PR activity, whereas the b-
wave seems to reflect bipolar andMüller cell function, andOPs, whose
origins are less clear, are thought to originate from feedback neural
pathways in the inner retina, especially around the inner plexiform
layer (IPL) and mainly from amacrine cells. At 4 weeks after SCGx,
the ERG a-wave amplitude from the ipsilateral retina significantly
decreased as compared to the contralateral retina submitted to a sham
Fig. 3. Effect of SCGx on the RPE melanin content and RPE65 immunoreactivity. (A) Representative photomicrographs showing RPE melanin content loss
(arrows) at the temporal (but not nasal) RPE at 800 µm from the ONH. Scale bar: 25 µm. (B) SCGx induced a significant decrease in melanin content in the
temporal RPE, which, at 4 weeks post-SCGx (black triangles), was evident at 800 µm temporally from the ONH and afterwards spread to almost all the
temporal side, except for the periphery (1600-2000 µm from the ONH), at 6 (white triangles) and 10 (black squares) weeks post-SCGx. No differences in the nasal
RPE melanin content were observed between control eyes (white circles) and SCGx eyes at all time points examined. Data are means±s.e.m. (n=5 animals
per group), **P<0.01 vs control eyes, by Tukey’s test. (C) Representative RPE photomicrographs of RPE65 immunostaining at 800 µm nasally and temporally
from the ONH. A decrease in RPE65 immunostaining in the temporal (but not nasal) RPE was observed in eyes submitted to SCGx at 4, 6 and 10 weeks
post-surgery. Shown are representative photomicrographs from five animals/group. OS, photoreceptor outer segments; RPE, retinal pigment epithelium; Ch,
choroid. Scale bar: 50 µm.
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procedure, and a further decrease in this parameter was observed at 6
and 10 weeks after SCGx. In contrast, there were no differences in
neither ERG b-wave nor in OP amplitudes even at 10 weeks after
SCGx. There is controversy about ERG responses in experimental
models of AMD, with no differences in ERG amplitudes (Vessey
et al., 2015), a decrease in the ERG a-wave (Huang et al., 2017) or a
decrease in both ERG a- and b-wave amplitude (Justilien et al., 2007;
Mao et al., 2014; Rakoczy et al., 2006; Yao et al., 2015; Zhao et al.,
2011). In those models in which a decrease in ERG response was
described, functional alterations are evident in mice at age 3-
17 months, whereas the effect of SCGx on retinal function was
already evident at 4 weeks post-surgery. The fact that only the ERG a-
wave amplitude decreased after SCGx could reflect the limited
localization of the SCGx-induced retinal damage, which seems to
affect exclusively the outer retina. In that sense, it should be noted that,
as in other retinal injuries (Fernandez et al., 2009), ERG disturbance
predated PR morphological changes, supporting that the ERG could
be a sensitive indicator of retinal damage because the functional
measurement revealed injury at a timewhen PRmorphology appeared
relatively normal.
Time-dependentRPEultrastructural alterationswere found inAMD
human eyes (Bhutto and Lutty, 2012; Boulton and Dayhaw-Barker,
2001) and AMD-like mouse models (Mao et al., 2014; Rakoczy et al.,
2006; Ramkumar et al., 2010). In the temporal RPE, progressive
structural alterations, such as a decrease in melanin granules, followed
by the occurrence of mid electron-dense granules (compatible with
lipofuscin and/or melanolipofuscin), especially near the basal
infoldings, were found and, later on, big vacuoles with membranous
debris and irregular nuclei appeared. As for the PR ultrastructure, gaps
between discmembranes, and even outer segment blebs and loss, were
evident at 6 and 10 weeks post-surgery in the same regions in which
the RPE was highly vacuolated (i.e. the temporal retina).
Two hypotheses have been proposed regarding AMD
pathogenesis. One is that RPE atrophy causes choriocapillaris
alterations and PR degeneration, and the other is that choroidal
vascular insufficiency provokes secondary RPE and PR dysfunction
and degeneration (McLeod et al., 2009). Supporting the former
hypothesis, it has been demonstrated that the selective destruction of
the RPE by the administration of sodium iodate (Korte et al., 1984)
or mechanical debridement (Leonard et al., 2003) causes atrophy of
Fig. 4. Retinal histology, sub-retinal deposit analysis, and ONL and RPE apoptosis. (A) Representative retinal semi-thin sections at 800 µm nasally and
temporally from the ONH stained with Toluidine Blue from control eyes and eyes submitted to SCGx are shown. Besides the loss of RPE melanin content (white
asterisk) at 4 weeks post-SCGx, drusenoid deposits (white arrows) between temporal RPE and PRs were found at 6 weeks post-SCGx, followed by major
alterations in the temporal area such as RPE vacuolization (black arrow) and endothelial cell alterations (arrowhead), which were found at 10 weeks post-SCGx.
(B) C3 immunoreactivity in representative transverse retinal sections. Linear C3(+) deposits within the temporal BrM were observed at 6 and 10 weeks post-
SCGx. Shown are representative photomicrographs from five animals/group. Scale bars: 25 µm (A); 10 µm (B). (C) SCGx induced a significant increase in
TUNEL(+) nuclei (arrows) in the temporal ONL and RPE at 800 µm from the ONH at 10 weeks post-surgery. Representative photomicrographs from five animals/
group are shown. Scale bars: 25 μm (retina); 50 μm (RPE). RPE, retinal pigment epithelium; Ch, choroid; RPE, retinal pigment epithelium; OS, photoreceptor outer
segments; INL, inner nuclear layer; IPL, inner plexiform layer; ONL, outer nuclear layer; OPL, outer plexiform layer; GCL, ganglion cell layer; IS, photoreceptor
inner segments; C, control; SCGx, superior cervical gangliectomy. Data are means±s.e.m. (n=5 animals per group), **P<0.01 vs control eyes, by Student’s t-test.
6
RESEARCH ARTICLE Disease Models & Mechanisms (2018) 11, dmm031641. doi:10.1242/dmm.031641
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
the choriocapillaris. In contrast, it has been suggested that most
cases of AMD result from alterations of the choriocapillaris in the
submacular area (Duke-Elder, 1966); later on, a vascular model for
AMD was proposed (Friedman, 2008) and, more recently, it has
been demonstrated that choriocapillaris alterations precede RPE
and retina degeneration in human AMD (Biesemeier et al., 2014).
Our results demonstrate that choroid sympathetic denervation
recapitulated the main features of human GA, such as focal BrM
thickening, pseudodrusen, and RPE and PR alterations, supporting
that a choroid/choriocapillaris alteration could be a primary event
in AMD. Notwithstanding, as pointed by McLeod et al. (2009) and
Bhutto and Lutty, (2012), RPE and choriocapillaris share a
mutualistic relationship and, if one of the components is pathologic
or compromised, either or both may become dysfunctional or may
degenerate, suggesting that perhaps both hypotheses are not mutually
exclusive and, consequently, in an AMD ‘scenario’ there may not
necessarily be a primary insult leading to atrophy but rather a
concerted deterioration affecting the entire complex (choroid/
choriocapillaris/BrM/RPE/PRs).
Care must be taken when extrapolating data generated in rodents
to humans. In that sense, the relevance of our study to human GA is
still an open question. Genetic engineering, immunological
manipulation or mouse strains with spontaneously arising retinal
degeneration have been widely used to generate models that
simulate some of the features of human AMD and for investigating
the pathogenesis, treatment and prevention of the disease. Unlike
other retinal diseases that affect the peripheral retina, AMD
preferentially affects central vision and the macula. Thus, it is
difficult to model this disease in the mouse because the mouse retina
lacks a macula. However, it should be taken into account that recent
evidence may argue on this point, since a central area with a highest
rod concentration and BrM and RPE specialization were described
in C57BL/6J mice (Volland et al., 2015). Why the human macula is
more susceptible to degeneration in AMD is still unknown, and the
same question holds for the discrete damage in the temporal region
observed after SCGx in mice. Volland and co-workers (Volland
et al., 2015) have shown that a central area of the mouse retina
possesses some of the structural characteristics that, in the human
retina, have been suggested to make the macula more susceptible to
degeneration. Therefore, the identification of the mechanisms that
make the temporal side more sensitive to damage induced by SCGx
could contribute to understanding the particular susceptibility of the
macula. In any case, even assuming that this disadvantage is shared
with all other mouse models for AMD, the present results
demonstrate that SCGx in C57BL/6J mice recapitulated central
features of human GA, with the clear advantage of inducing AMD-
like alterations in a particular region, corresponding to the mouse
central retina described by Volland et al. (2015). Moreover, the
relatively simple procedure of removing the SCG to induce AMD-
like disease has the advantage of being applicable to larger animals
with cone-rich central retinas or even to primates with macula,
without needing any genetic manipulation. Furthermore, since most
Fig. 5. Effect of SCGx on retinal function. (A-C) The average amplitudes of scotopic ERG a-wave, b-wave andOPs are shown. A significant decrease in ERG a-
wave amplitude was observed after 4, 6 and 10 weeks post-SCGx (white dots), whereas no alterations in the ERG b-wave and OP amplitudes were found at
any time point studied. Gray bars show naïve ERGa- and b-wave andOPamplitudes. No differences were found between naïve and control eyes (black dots) in all
parameters and time points studied. Data are means±s.e.m. (n=10 animals per group), *P<0.05 and **P<0.01 vs naïve eyes, by Tukey’s test. (D) Representative
scotopic ERG and OP traces of control eyes and SCGx eyes.
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models in mice develop retinal lesions at older ages (6-24 months,
depending on the model), the relatively early onset of AMD-like
alterations induced by SCGx (i.e. at 4 weeks post-surgery) could be
another advantage for the use of this model in AMD research,
mainly considering that changes in the choroid/BM/RPE/retina
structure and function can be influenced by aging per se (Curcio
et al., 2000; Gao and Hollyfield, 1992; Jackson et al., 2002; Vessey
et al., 2015). In this model, the progressive functional and
morphological changes allow a reasonable time window to apply
therapies aiming both to prevent the onset of experimental AMD
(i.e. before 4 weeks post-SCGx) and to slow down the progression
of the disease in different stages (i.e. between 4 and 6 weeks post-
SCGx). Therefore, this new experimental model of GA could not
only provide insights into AMD etiology, but help to design new
therapeutic treatments for the disease.
MATERIALS AND METHODS
Animals
All animal use procedures were in strict accordance with the National
Institutes of Health (NIH) Guide for Care and Use of Laboratory Animals.
The ethics committee of the University of Buenos Aires School of Medicine
[Institutional Committee for the Care and Use of Laboratory Animals
(CICUAL)] approved this study. Adult male C57BL/6J mice (average
weight of 27±3 g and average age of 2.5±0.5 months) were housed in a
standard animal room with food and water ad libitum, under controlled
conditions of humidity and temperature (21±2°C). The room was lighted by
fluorescent lights (200 lux), which were turned on and off automatically
every 12 h (on from 8.00 AM to 8.00 PM). For all experimental procedures,
the animals were anesthetized with intramuscular injection of 100 mg kg−1
ketamine hydrochloride and 2 mg kg−1 xylazine hydrochloride.
Superior cervical gangliectomy
A ventral midline incision was made in the neck and the left SCG was
removed aseptically, as previously described (Romeo et al., 1991). This
procedure produces complete and permanent loss of ipsilateral orbital
sympathetic innervation. Care was taken to avoid carotid artery tears.
Incision was closed with 7-0 nylon sutures. All mice recovered without any
sign of distress. A sham procedure, without removing the right SCG, was
performed, and the right eye was then considered the control eye. In some
animals, while keeping the contralateral side intact, a sham procedure was
performed without excision of the left SCG. In these animals, the right eye
was called naïve. All animals were randomized before any experimental
procedure was done and all investigators involved were blind to treatment.
Histological evaluation
Mice were anesthetized and intracardially perfused with PBS, followed by a
fixative solution containing 4% formaldehyde in 0.1 mol l−1 PBS (pH 7.4)
using an ad hoc pump. Then, the eyeballs were carefully removed and post-
fixed overnight in the same fixative. For orientation (nasal/temporal axis),
Fig. 6. Effect of SCGx on the RPE and PR ultrastructure. Shown are representative transverse ultrathin RPE (A) and PR (B) sections from sham-treated eyes
and eyes at 4, 6 and 10 weeks post-SCGx. (A) At 6 weeks post-surgery, SCGx induced the occurrence of vacuoles (black arrow) adjacent to the temporal (at
800 µm from the ONH) RPE basal infoldings. These changes were more evident, and vacuoles appeared more apical and often filled with membranous content
(asterisk), at 10 weeks post-SCGx. Moreover, granules of middle-high electron-density were also present at the temporal RPE at 10 weeks post-SCGx (white
arrow). No differences were observed at the nasal RPE between control and SCGx eyes at any time point studied. Shown are representative photomicrographs
from five animals/group. OS, photoreceptors outer segments; RPE, retinal pigment epithelium; BI, basal infoldings. Scale bar: 200 nm. (B) SCGx induced focal
losses of plasmatic membrane (black arrow) and the replacement of discs with an electron-dense material (white asterisk) in the temporal retina at 6 weeks post-
surgery. These alterations were more evident at 10 weeks post-SCGx, and focal complete losses of discs and blebs (black asterisk) were observed. There were
no alterations in nasal PR outer segment plasmatic membrane (white arrow) and discs (white arrowhead) between control and SCGx eyes at any time point
studied. Shown are representative photomicrographs from five animals/group. Scale bar: 200 nm.
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nictitatingmembrane was left attached to the eye. After dehydration, eyes were
embedded in paraffin wax and sectioned (5 µm) along the horizontal meridian
through the ONH. Only sections where both the optic nerve and nictitating
membrane were distinguishable were used. Sections were stained with
hematoxylin and eosin,mountedwith Canada balsam and analyzed bymasked
observers. Light microscopic images were digitally captured with a
microscope (Eclipse E400, Nikon, Tokyo, Japan) using a 6-V halogen lamp
(20 W; equipped with a stabilized light source) and a camera (Coolpix s10,
Nikon, Abingdon, VA, USA). The average thickness of the total retina (TRT),
IPL, inner nuclear layer (INL), outer plexiform layer (OPL), ONLand PRouter
segments (OS) were measured for each eye. For each sample, measurements
(×400) at 200 µm steps from the ONH to the nasal and temporal periphery
were obtained and averaged from four separate sections, and the mean of five
eyes was recorded as the representative value for each group.
RPE melanin content quantification
Paraffin wax sections were deparaffinized, dehydrated and mounted in
Canada balsam without any other treatment, in order to avoid any
interference in the final result. Light microscopic images (×1000) were
digitally captured, and analyzed bymasked observers. For each eye, the total
section was reconstructed and divided each 200 µm steps nasally and
temporally from the ONH, taken as zero. As a result, progressively
equidistant eccentricities from the ONH to the nasal or temporal periphery
and a total of 20 areas, each 200 µm long, were obtained. The pigment area
present only in the RPE of each area was quantified using ImageJ software
version 1.42q (NIH, Bethesda, MD, USA), and the average from four
separate sections per eye, and the mean of five eyes, was recorded as the
representative value for each group.
Immunohistochemical studies
Antigen retrieval was performed by heating slices at 90°C for 30 min in citrate
buffer (pH 6.3). Sections were immersed in 0.1% Triton X-100 (Roche
Diagnostics GmbH, Mannheim, Germany) in 0.1 mol l−1 PBS for 20 min for
permeabilization. Sections were preincubated with 5% normal horse serum for
1 h and then were incubated overnight at 4°C with primary antibodies. The
following primary antibodies were used: a rabbit polyclonal anti-TH antibody
(1:500, Pel-Freeze Biologicals, Arkansas, AR, USA, P40101-0), a mouse
polyclonal anti-retinoid isomerohydrolase (RPE65) antibody (1:500; EMD
Millipore, Darmstadt, Germany, MAB5428), a rabbit polyclonal anti-
complement component 3 (C3) antibody (1:100; Abcam, Cambridge, MA,
USA, ab11887) and a mouse monoclonal anti-glial fibrillary acidic protein
(GFAP) antibody conjugated to Cy3 (1:1200; Sigma Chemical Co., St Louis,
MO, USA, C9205), a goat anti-Brn3a antibody (1:500; Santa Cruz
Biotechnology, Inc., sc-31984). After several washings, secondary antibodies
were added, and sectionswere incubated for 2 h at room temperature. Regularly,
some sections were treated without the primary antibodies to confirm
specificity. The following secondary antibodies were used: a goat anti-rabbit
IgM secondary antibody conjugated to Alexa Fluor 488 (1:500; Invitrogen,
Molecular Probes, Carlsbad, CA, USA, A11034), a goat anti-mouse IgM
secondary antibody conjugated to Alexa Fluor 568 (1:500; Invitrogen,
Molecular Probes, Carlsbad, CA, USA, A11031), a goat anti-rabbit IgM
secondary antibody conjugated to Alexa Fluor 568 (1:500; Invitrogen,
Molecular Probes, Carlsbad, CA, USA, A11036) and a donkey anti-goat
secondary antibody conjugated to Alexa Fluor 568 (1:500; Invitrogen,
Molecular Probes, Carlsbad, CA, USA, A11057). Nuclei were stained with
Hoechst (1 µg ml−1 Sigma Chemical Co., St Louis, MO, USA), mounted with
fluorescent mounting medium and observed under an epifluorescence
microscope (BX-50; Olympus, Tokyo, Japan) mounted with a video camera
(3CCD; Sony, Tokyo, Japan) attached to a computer running image analysis
software (Optimus,MediaCybernetics, Silver Spring,MD,USA).Comparative
digital images from different samples were grabbed using identical time
exposition, brightness and contrast settings. Although images from the whole
retinal section were taken, only images at 800 µm nasally and temporally from
the ONH (as described above) are shown for practical purposes.
Morphometric analysis
All the images obtained were assembled and processed using Adobe
Photoshop SC (Adobe Systems, San Jose, CA, USA) to adjust the
brightness and contrast. No other adjustments were made. For all
morphometric image processing and analysis, digitalized captured TIFF
images were transferred to ImageJ software version 1.42q (NIH, Bethesda,
MD, USA). The analyzers were masked for treatment and time point in all
experiments.
TUNEL analysis
For DNA fragmentation of cells undergoing apoptosis, the ApopTag®
Fluorecein In Situ Apoptosis Detection Kit (S7110; Chemicon, CA, USA)
was used according to the manufacturer’s instructions. For each section, the
number of TUNEL(+) cells in the ONL and RPE from the nasal or temporal
retina was calculated. For each eye, results obtained from four separate
sections were averaged and the mean of five eyes was recorded as the
representative value for each group.
Electron microscopy
Mice were intracardially perfused with PBS 0.1 M pH 7.4, containing
0.5 ml heparin and 2.4% sodium nitroprusside as vasodilator, followed by a
fixative solution containing 2% glutaraldehyde and 4% formaldehyde. Eyes
were carefully removed, and corneas and lenses removed. The nictitating
membrane was left attached to the eye for orientating purposes. Eye-cups
were sectioned along the horizontal meridian through the ON and post-fixed
with 1% osmium tetroxide for 2 h on ice. Samples were embedded in epoxy
resin. Ultrathin sections (50 nm) from the nasal and temporal retina (at
800 µm from the ONH) were obtained using glass knives and an
ultramicrotome Ultracut E (Reichert-Jung, Vienna, Austria). Sections
were mounted on 300 Mesh grids and stained with uranyl acetate (2% in
70% ethanol) and Reynolds lead citrate. Finally, sections were viewed and
photographed using a Zeiss 109T transmission electron microscope (Carl
Zeiss Microscopy, Peabody, MA, USA) equipped with a digital camera
(ES1000W; Gatan, Pleasanton, CA, USA).
ERG recording
Standard scotopic electroretinographic activity was assessed before and at 2,
4, 6 and 10 weeks post-unilateral SCGx. After an overnight dark adaptation,
mice were anesthetized under dim red illumination. Phenylephrine
hydrochloride and tropicamide were used to dilate the pupils, and the
cornea was intermittently irrigated with balanced salt solution to maintain
the baseline recording and to prevent keratopathy. Recordings were made
with a HMsERG model 2000 (Ocuscience LLC, Kansas City, MO, USA)
equipped with a Ganzfield dome fitted with a white-light-emitting-diode
stimulus at a distance of 2 cm from the eye. For each test, 15 full-field flashes
(2 ms each) separated by a 60 s interval [flash intensity 10 cd s m−2 (candela
seconds per square meter) or 0.5 log standard flash (SF)] were averaged. The
band pass of the amplifiers was 0.3-300 Hz. A reference electrode was
placed through the ear, a grounding electrode was attached to the tail and a
silver embedded thread electrode with a 2.5 mm lens (Ocuscience, Rolla,
MO, USA) was placed in contact with the central cornea. A 15 W red light
was used to enable accurate electrode placement. This procedure did not
significantly affect dark adaptation and was switched off during the
electrophysiological recordings. The a-wave was measured as the difference
in amplitude between the recording at onset and the trough of the negative
deflection, and the b-wave amplitudewas measured from the trough of the a-
wave to the peak of the ERG.Mean values from each eyewere averaged, and
the resultant mean value was used to compute the group means a- and b-
wave amplitude±s.e.m. OPs were assessed by filtering of the ERG
recordings applying filters of high (140 Hz) or low (100 Hz) frequency
with HMsERG software version 3.6 (Ocuscience, Rolla, MO, USA). The
amplitudes of the OPs were estimated by measuring the heights from the
baseline drawn between the troughs of successive wavelets to their peaks.
Mean values from each eye were averaged, and the resultant mean value was
used to compute the group OPs amplitude±s.e.m.
Fundus imaging
After 10 weeks post-SCGx, mice were anesthetized as described above,
pupils were dilated with 2.5% phenylephrine, and 0.5% proparacaine (Alcon
Laboratories, Argentina) was applied for topical anesthesia. When full
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mydriasis was achieved, the anesthetized animal was placed in lateral
recumbency under the surgical microscope (LAB 5 LED, Newton, Buenos
Aires, Argentina) with coaxial light, and positioned with one holding hand.
The fundus was visualized with the application of a slide glass, with a drop
of 2.5% methylcellulose (Poen Laboratories, Argentina) placed on the
contact area of the cornea. Fundus photographs from the central retina (i.e.
when the optic nerve head appeared in the center of the screen) were
obtained using a digital camera (Coolpix s10; Nikon, Abingdon, VA, USA)
adapted to the microscope.
Statistical analysis
Statistical analysis of results was made by a Student’s t-test or a one-way
analysis of variance (ANOVA) followed by a Tukey’s test, as stated, and met
the necessary assumptions. The assumption of equal variances was tested by
the F-test. In every statistical analysis, P<0.05 was considered statistically
significant.
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